MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Neuropsychological Predictors of Cognitive Decline in Parkinson’s Disease: A Systematic Review (PDCogniCare)

D. Pourzinal, K. Sivakumaran, J. Yang, D. Bailey, L. Mitchell, D. Brooks, A. Lehn, J. Liddle, N. Pachana, H. Tinson, K. Shrubsole, N. Dissanayaka (Herston, Australia)

Meeting: 2024 International Congress

Abstract Number: 261

Keywords: Cognitive dysfunction, Dementia, Parkinson’s

Category: Parkinson's Disease: Cognitive functions

Objective: This systematic review aimed to synthesise current neuropsychological predictors of cognitive decline in Parkinson’s disease (PD).

Background: The observed heterogeneity of cognitive function in PD may be attributed to the variability in measures used to assess cognition from clinic to clinic. To propose recommendations for a PD-specific cognitive toolkit, we evaluated the predictive utility of neuropsychological measures to predict cognitive decline in PD.

Method: Systematic literature searches were performed in PubMed, SCOPUS, Medline, PyscINFO and CINAHL databases with terms related to ‘longitudinal’, ‘predictor’, ‘cognitive decline’, ‘dementia’, and ‘PD’. Articles published up to July 2023 were screened by two independent reviewers, following PRISMA guidelines. Quality was assessed using the Newcastle-Ottawa scale for individual studies and the GRADE system for each cognitive outcome.

Results: Twenty-eight articles with low to moderate risk of bias were included. The highest grade of evidence was produced for category verbal fluency, Trail-making A, Symbol Digit Modalities Test, measures of immediate verbal memory, and the Montreal Cognitive Assessment, supporting their utility in PD. Low quality evidence supporting use of the Trail-making B, Stroop test, Letter Number Sequencing, pentagon copying, and measures of delayed verbal and visual memory in PD was produced. Consistent evidence against the predictive utility of letter fluency and digit span measures was produced, and eight other measures produced very low quality of evidence due to insufficient studies / mixed results.

Conclusion: Our critical summary of the evidence base for key neuropsychological predictors of cognitive decline in PD will ultimately be used to inform evidence-based clinical practice guidelines for the evaluation and diagnosis of cognitive impairment in PD (PDCogniCare).

To cite this abstract in AMA style:

D. Pourzinal, K. Sivakumaran, J. Yang, D. Bailey, L. Mitchell, D. Brooks, A. Lehn, J. Liddle, N. Pachana, H. Tinson, K. Shrubsole, N. Dissanayaka. Neuropsychological Predictors of Cognitive Decline in Parkinson’s Disease: A Systematic Review (PDCogniCare) [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/neuropsychological-predictors-of-cognitive-decline-in-parkinsons-disease-a-systematic-review-pdcognicare/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/neuropsychological-predictors-of-cognitive-decline-in-parkinsons-disease-a-systematic-review-pdcognicare/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley